This inventor holds 1 USPTO granted patent. Top assignees: Amgen Inc., Other. Active years: 1996.
Company Filing History:
1 out of 2,067 
1 out of 834,350 Years Active: 1996
Title: The Innovations of Claudio Brancolini
Introduction
Claudio Brancolini is a notable inventor based in Trieste, Italy. He has made significant contributions to the field of biotechnology, particularly in the area of receptor stimulation. His work has implications for various therapeutic applications.
Latest Patents
Brancolini holds a patent for "DNA encoding a stimulating factor for the axl receptor." This invention identifies and sequences a protein known as gas6, which acts as a stimulator and presumed ligand for the axl receptor. The gas6 protein shows homology to human protein S and serves as a growth factor for tissues that express axl. This patent highlights his innovative approach to understanding and manipulating biological processes.
Career Highlights
Throughout his career, Claudio Brancolini has worked with prominent companies, including Amgen Inc. His experience in the biotechnology sector has allowed him to develop groundbreaking technologies that advance scientific knowledge and medical treatments.
Collaborations
Brancolini has collaborated with esteemed colleagues such as Claudio Schneider and Giancarlo Avanzi. These partnerships have fostered a collaborative environment that enhances research and innovation.
Conclusion
Claudio Brancolini's contributions to biotechnology, particularly through his patent on the axl receptor, demonstrate his commitment to advancing scientific understanding. His work continues to influence the field and inspire future innovations.